companydata.dkcompanydata.dk

Aptol Pharma ApS: Financial statements 2019

CVR: 39308967

Source: annual report 2019, Danish Business Authority

01/01/201931/12/2019

Aptol Pharma ApS (CVR 39308967) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -101,800 and a net result of DKK -2,348 compared with DKK 128,964 the year before. Equity in the 2019 report amounted to DKK 50,000. The solvency ratio was 100%.

Revenue
DKK 0
Gross Profit
DKK -101,800
Profit/Loss
DKK -2,348
Equity
DKK 50,000
Total Assets
DKK 50,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20190-102 t.-2 t.50 t.-
2018089 t.129 t.50 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Kira Gerber Petersen joins the board of Aptol Pharma ApSDec 13, 2019

As of December 13, 2019, Kira Gerber Petersen has joined the board of directors of Aptol Pharma ApS.

Integrated biomedical technologies ApS changes name to IBIO TECH ApSDec 13, 2019

On December 13, 2019, the company changed its name from Integrated biomedical technologies ApS to IBIO TECH ApS.

Kira Gerber Petersen leaves the board of Aptol Pharma ApSDec 12, 2019

As of December 12, 2019, Kira Gerber Petersen has left the board of directors of Aptol Pharma ApS.

Aptol Pharma ApS publishes interim reportJan 2, 2019

Aptol Pharma ApS has published its interim report for the period February 5, 2018 – December 31, 2018.

About Aptol Pharma ApS

Aptol Pharma ApS is a Danish company of the type Anpartsselskab based in København SV, founded in 2018. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named IBIO TECH ApS and Integrated biomedical technologies ApS. The company's owners include ADT HOLDING ApS, Tue Wenzel Kragstrup and Peter Andreas Nicolai Reumert Wagtmann. According to the 2024 annual report, the company had an average of 1 employee. In 2024, the company reported a gross profit of DKK 2,442 and a net result of DKK -131,289 compared with DKK 307,979 the year before. Equity in the 2024 report amounted to DKK -140,336.

Source: annual report 2024, Danish Business Authority

Other financial years